TCI Wealth Advisors’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-294
Closed -$14K 2677
2022
Q3
$14K Hold
294
﹤0.01% 850
2022
Q2
$13K Buy
+294
New +$16.2K ﹤0.01% 875
2022
Q1
Sell
-9
Closed -$1K 2503
2021
Q4
$1K Hold
9
﹤0.01% 2260
2021
Q3
$1K Sell
9
-89
-91% -$11.6K ﹤0.01% 2331
2021
Q2
$16K Buy
98
+15
+18% +$2.34K ﹤0.01% 696
2021
Q1
$12K Buy
83
+74
+822% +$12.1K 0.01% 784
2020
Q4
$2K Hold
9
﹤0.01% 1297
2020
Q3
$1K Sell
9
-3
-25% -$401 ﹤0.01% 1469
2020
Q2
$1K Buy
12
+3
+33% +$356 ﹤0.01% 1394
2020
Q1
$1K Buy
+9
New +$1.08K ﹤0.01% 1386

Other funds holding NVRO

TCI Wealth Advisors's NVRO Position: Q4 2022 in Review

TCI Wealth Advisors sold out of NEVRO CORP. (NVRO) in Q4 2022, closing a stake of 294 shares — an estimated $14K sold.

TCI Wealth Advisors first reported a position in NVRO in Q1 2020 and held it in 10 quarters. The position peaked at $16K in Q2 2021. 170 funds tracked by Wall St. Rank hold NVRO as of Q4 2022.

  • TCI Wealth Advisors reported no remaining NEVRO CORP. position as of Q4 2022 after selling out during the quarter.
  • TCI Wealth Advisors sold 294 NEVRO CORP. shares in Q4 2022, an estimated $14K.
  • TCI Wealth Advisors first reported a position in NEVRO CORP. in Q1 2020 and held it in 10 quarters.
  • TCI Wealth Advisors's NEVRO CORP. position peaked at $16K in Q2 2021.
  • 170 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2022.

Based on TCI Wealth Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.